| Daniel A Keenan Jr, MD | |
|
105 Buford Ave, Anderson, SC 29621-3313 | |
| (864) 512-8565 | |
| (864) 225-3317 |
| Full Name | Daniel A Keenan Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 105 Buford Ave, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598714305 | NPI | - | NPPES |
| 182248 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 18224 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
As part of the Psychology Invited Speakers Seminar Series at the University of Leicester, Professor Jason Hughes from the University's Department of Sociology will today argue that e-cigarettes, which are currently unregulated throughout the United Kingdom, will soon face legislation that will restrict and ban them - and that concerns about social dangers, more than physical dangers to health, will be the cause of it.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.
The BMA today welcomed the publication of two Scottish Executive reports into the education and training of the medical workforce in Scotland acknowledging that they offered many solutions but, warned that they would only be successful if the recommendations are followed and effective action is taken now.
Researchers at Baylor College of Medicine and collaborators at other institutions have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner.
› Verified 1 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
As part of the Psychology Invited Speakers Seminar Series at the University of Leicester, Professor Jason Hughes from the University's Department of Sociology will today argue that e-cigarettes, which are currently unregulated throughout the United Kingdom, will soon face legislation that will restrict and ban them - and that concerns about social dangers, more than physical dangers to health, will be the cause of it.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.
The BMA today welcomed the publication of two Scottish Executive reports into the education and training of the medical workforce in Scotland acknowledging that they offered many solutions but, warned that they would only be successful if the recommendations are followed and effective action is taken now.
Researchers at Baylor College of Medicine and collaborators at other institutions have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner.
› Verified 1 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
As part of the Psychology Invited Speakers Seminar Series at the University of Leicester, Professor Jason Hughes from the University's Department of Sociology will today argue that e-cigarettes, which are currently unregulated throughout the United Kingdom, will soon face legislation that will restrict and ban them - and that concerns about social dangers, more than physical dangers to health, will be the cause of it.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.
The BMA today welcomed the publication of two Scottish Executive reports into the education and training of the medical workforce in Scotland acknowledging that they offered many solutions but, warned that they would only be successful if the recommendations are followed and effective action is taken now.
Researchers at Baylor College of Medicine and collaborators at other institutions have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel A Keenan Jr, MD Po Box 100174, Columbia, SC 29202-3174 Ph: (864) 512-8565 | Daniel A Keenan Jr, MD 105 Buford Ave, Anderson, SC 29621-3313 Ph: (864) 512-8565 |
News Archive
Physicians apparently learn to "shut off" the portion of their brain that helps them appreciate the pain their patients experience while treating them and instead activate a portion of the brain connected with controlling emotions, according to new research using brain scans at the University of Chicago.
As part of the Psychology Invited Speakers Seminar Series at the University of Leicester, Professor Jason Hughes from the University's Department of Sociology will today argue that e-cigarettes, which are currently unregulated throughout the United Kingdom, will soon face legislation that will restrict and ban them - and that concerns about social dangers, more than physical dangers to health, will be the cause of it.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.
The BMA today welcomed the publication of two Scottish Executive reports into the education and training of the medical workforce in Scotland acknowledging that they offered many solutions but, warned that they would only be successful if the recommendations are followed and effective action is taken now.
Researchers at Baylor College of Medicine and collaborators at other institutions have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner.
› Verified 1 days ago
Shahzad H Sheikh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-5849 Fax: 864-512-7575 | |
Winston Cordell Floyd, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 North Fant Street, Suite G, Anderson, SC 29621 Phone: 864-224-2197 Fax: 864-225-0033 | |
David W Potts, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-3915 Fax: 864-260-3920 | |
Sanjeev Kumar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 819 N Fant St, Anderson, SC 29621 Phone: 864-261-1800 Fax: 864-261-1856 | |
Rajeev Malik, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Ste 5000, Anderson, SC 29621 Phone: 864-224-5765 Fax: 864-224-1449 | |
Daniel W. Grisham Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St Ste 2300, Anderson, SC 29621 Phone: 864-512-5780 Fax: 864-375-1155 | |
Dr. William Muirhead Turner, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 Addis Cir, Anderson, SC 29626 Phone: 864-934-6833 |